Hong Kong Infrastructure Stock News

With a price-to-earnings (or "P/E") ratio of 7.5x The United Laboratories International Holdings Limited ( HKG:3933...

Earnings and dividend decision set the tone for Hang Lung Properties Hang Lung Properties (SEHK:101) has put investors' attention on its latest full year earnings, which showed lower sales and net income, alongside a recommended final cash dividend of HK$0.40 per share. See our latest analysis for Hang Lung Properties. Despite the softer full year earnings, Hang Lung Properties’ recent share price performance has been positive, with a 30 day share price return of 3.38% and an 8.72% share...

As the Asian markets navigate a landscape marked by global volatility and shifting investor sentiment, opportunities continue to emerge for those looking beyond traditional large-cap investments. Penny stocks, often associated with smaller or newer companies, remain an intriguing area of focus due to their potential for growth and affordability. While the term may seem outdated, these stocks can offer significant value when backed by strong financials, as demonstrated by the three noteworthy...

Unfortunately for some shareholders, the Sinohope Technology Holdings Limited ( HKG:1611 ) share price has dived 26% in...

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Why Datang International Power Generation stock is in focus Datang International Power Generation (SEHK:991) issued preliminary 2025 guidance indicating net profit attributable to equity holders of about CN¥6.8b to CN¥7.8b, with net profit after non recurring items projected at CN¥7.2b to CN¥8.2b. See our latest analysis for Datang International Power Generation. The latest guidance and 2025 operating update land after a mixed period for the share price, with Datang International Power...

Key Insights Dongfang Electric's significant private companies ownership suggests that the key decisions are influenced...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Key Insights Laopu Gold's significant private companies ownership suggests that the key decisions are influenced by...

Key Insights The considerable ownership by private companies in China Resources Beer (Holdings) indicates that they...

As global markets navigate a period of volatility marked by concerns over artificial intelligence and geopolitical tensions, investors are increasingly turning their attention to Asia's growth potential. In this environment, stocks with high insider ownership can offer unique insights into companies' long-term prospects, as insiders often have a vested interest in the success of the businesses they help manage.

As Asian markets navigate a period of economic shifts and evolving investor sentiment, the focus has increasingly turned to the potential of smaller-cap stocks. Penny stocks, while often seen as remnants of past market eras, continue to offer intriguing opportunities for investors seeking growth at accessible price points. By examining those with strong financial foundations and clear growth potential, we can uncover compelling investment prospects within this often overlooked segment.

CARsgen Therapeutics Holdings (SEHK:2171) issued preliminary 2025 earnings guidance indicating a sharp year on year reduction in net loss, driven by commercial activity, lower research costs, and foreign exchange effects. See our latest analysis for CARsgen Therapeutics Holdings. CARsgen Therapeutics Holdings’ latest guidance lands after a volatile stretch, with a 6.32% 1 day share price return to HK$14.13 following recent weakness, including a 13.74% 30 day share price decline. The 1 year...

Why the TQA3605 trial update matters for Sino Biopharmaceutical Sino Biopharmaceutical (SEHK:1177) has drawn investor attention after reporting that its HBV candidate TQA3605 met the primary endpoint in a Phase II trial, combining with nucleos(t)ide analogues for chronic hepatitis B patients. The randomized, double blind, placebo controlled study enrolled 122 subjects and compared several TQA3605 dose groups with a nucleos(t)ide analogue only control arm. All active dose groups reached around...

Hangzhou SF Intra-city Industrial Co., Ltd. ( HKG:9699 ) shareholders would be excited to see that the share price has...

Digital Domain Holdings Limited ( HKG:547 ) shares have had a horrible month, losing 27% after a relatively good period...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...

Damai Entertainment Holdings Limited ( HKG:1060 ), might not be a large cap stock, but it saw a decent share price...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

By buying an index fund, investors can approximate the average market return. But if you buy good businesses at...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Lapco Holdings Limited ( HKG:8472 ) shares have had a horrible month, losing 26% after a relatively good period...